IPOPLUS

237.96

+3.15 +1.34%

18 Jun 2026

NSE Listed

Zuari Agro Chemicals Limited (ZUARI)

Volume: 65,897Avg Vol 1W: 1,12,894.2Avg Vol 1M: 1,79,047.0552W Range:175.1393.55
₹237.96 1.34%
Key Ratios
Updated 8h ago
Market Cap₹909 Cr
Current Price₹237.96
Previous Close₹234.81
High / Low (52w)₹393.55 / ₹175.1
Volume65,897
Avg Vol (1W)1,12,894.2
Avg Vol (1M)1,79,047.05
Stock P/E
Book Value₹496.67
Dividend Yield0%
ROE12.2%
ROA30.2%
Revenue (TTM)₹4,490 Cr
Revenue Growth-3.5%
Profit Margin28.8%
Total Debt₹56 Cr
Shares Outstanding4 Cr
Face Value₹10
EPS (TTM)₹-5.94
P/B0.44
Debt / Equity0.31
50 DMA₹218.87
200 DMA₹269.28
Day change+1.34%
Price Chart
237.96 13.03% · 1Y
3841812.5Cr
2025-06-17
2026-05-11

20-day avg volume: 1.8L shares

Pros
  • Company is almost debt-free.
  • Revenue grew 25% YoY.
  • Stock trades below its book value.
Cons
  • Company is loss-making at the latest annual result.
Quarterly Results
MetricJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue₹1,097 Cr₹1,123 Cr₹1,264 Cr₹952 Cr₹1,246 Cr₹1,423 Cr₹344 Cr₹187 Cr
EBITDA₹103 Cr₹93 Cr₹96 Cr₹29 Cr₹122 Cr₹153 Cr₹6 Cr₹-11 Cr
Net Profit₹9 Cr₹81 Cr₹55 Cr₹20 Cr₹99 Cr₹806 Cr₹40 Cr₹-25 Cr
EPS
Profit & Loss (Annual)
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹3,085 Cr₹2,466 Cr₹3,650 Cr₹4,647 Cr₹4,773 Cr₹4,490 Cr
EBITDA₹106 Cr₹200 Cr₹226 Cr₹347 Cr₹439 Cr₹321 Cr
Net Profit₹-802 Cr₹-157 Cr₹130 Cr₹477 Cr₹100 Cr₹165 Cr
EPS
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹6,563 Cr₹5,372 Cr₹6,262 Cr₹5,052 Cr₹4,820 Cr₹5,026 Cr
Total Liabilities₹5,807 Cr₹4,733 Cr₹5,418 Cr₹2,937 Cr₹2,530 Cr₹2,509 Cr
Equity₹755 Cr₹639 Cr₹844 Cr₹2,114 Cr₹2,290 Cr₹2,517 Cr
Total Debt₹292 Cr₹127 Cr₹113 Cr₹163 Cr₹424 Cr₹56 Cr
Cash Flow
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹2,644 Cr₹1,502 Cr₹595 Cr₹147 Cr₹579 Cr₹574 Cr
Investing₹-16 Cr₹-171 Cr₹-137 Cr₹426 Cr₹3 Cr₹-122 Cr
Financing₹-2,404 Cr₹-1,188 Cr₹-296 Cr₹-697 Cr₹-527 Cr₹-494 Cr
Free Cash Flow₹2,644 Cr₹1,502 Cr₹595 Cr₹147 Cr₹579 Cr₹574 Cr

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search